Elite is developing differentiated niche generic products for future growth. Elite’s focus is on solid oral dose products that are hard to formulate, such as extended-release products and products that we believe have competitive advantages. Elite also continues to evaluate contract development, contract manufacturing, and in-licensing opportunities. Updates on development projects will be provided upon achieving key milestones.
